Latest News
Oncolytics Biotech Inc.
- Form 8K Oncolytics Biotech Inc. For: 20 October By Investing.com
- Oncolytics Biotech (ONCY) to Present REO 033 Trial Data at ESMO Congress 2026
- Form 8K Oncolytics Biotech Inc. For: 20 October By Investing.com
- Oncolytics Biotech Completes GOBLET Pancreatic Cancer Cohort Enrollment
- Oncolytics Biotech: Pelareorep’s Clinical Progress Faces a Critical Funding Test
- Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026
- Oncolytics Biotech expects final PanCAN grant payment, Cohort 4 data due Q4 2026
- Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
- Oncolytics Biotech secures new cancer immunothe...
- Oncolytics Biotech® Announces Publication Demonstrating
- Oncolytics reports pelareorep data in liver cancer study By Investing.com
- Oncolytics Biotech® Reports Accelerating Enrollment in
Headlines from the last 30 days, linking to the original publishers. See all market news →